VNDRIQ — Vendor Comparison
Ibex Medical Analytics vs Proscia
Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.
Ibex Medical Analytics
Digital Pathology AI
Last verified: September 30, 2026
Proscia
Digital Pathology AI
Last verified: September 16, 2026
VNDRIQ Scores
47
Overall
71
Overall
Approval Tier
BAA Status
PHI Exposure Risk
AI Training Risk
HIPAA Risk Level
Review Frequency
Quarterly
Quarterly
Recommended Use
Clinical decision support for pathologists in prostate cancer diagnosis using the FDA-cleared Ibex Prostate Detect software.
Primary pathology diagnosis using whole slide imaging (WSI) in clinical laboratories, specifically for FFPE tissue specimens.
Restrictions
Only Ibex Prostate Detect is FDA-cleared; other solutions (breast, gastric) are Research Use Only (RUO) in the United States.
Concentriq AP-Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens. Native AI features and interoperable AI applications are currently for Research Use Only (RUO) in many contexts.
Executive Summary
Ibex Medical Analytics
Digital Pathology AI
Ibex Medical Analytics is classified as Approved With Restrictions with a BAA status of Available upon request for clinical customers. PHI exposure is rated High and AI training risk is High. Clinical decision support for pathologists in prostate cancer diagnosis using the FDA-cleared Ibex Prostate Detect software.
36
Privacy
71
Governance
49
Healthcare
30
AI Risk
Proscia
Digital Pathology AI
Proscia is classified as Approved With Restrictions with a BAA status of Available for clinical customers; the platform aligns with HIPAA and GDPR privacy standards.. PHI exposure is rated Medium and AI training risk is Low. Primary pathology diagnosis using whole slide imaging (WSI) in clinical laboratories, specifically for FFPE tissue specimens.
61
Privacy
71
Governance
63
Healthcare
90
AI Risk
Recommended For
Ibex Medical Analytics
Clinical decision support for pathologists in prostate cancer diagnosis using the FDA-cleared Ibex Prostate Detect software.
Organizations with established governance workflows
Multi-location healthcare groups needing standardized vendor status
Proscia
Primary pathology diagnosis using whole slide imaging (WSI) in clinical laboratories, specifically for FFPE tissue specimens.
Organizations with established governance workflows
Multi-location healthcare groups needing standardized vendor status
Governance Considerations
Ibex Medical Analytics
Verify model training opt-out clauses before deployment.
PHI exposure is elevated. Review data flow documentation.
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Only Ibex Prostate Detect is FDA-cleared; other solutions (breast, gastric) are Research Use Only (RUO) in the United States.
Proscia
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Concentriq AP-Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens. Native AI features and interoperable AI applications are currently for Research Use Only (RUO) in many contexts.
Questions to Ask Before Approval
Has the vendor executed a Business Associate Agreement (BAA) with your organization?
Does the vendor use customer data to train AI models? Can you opt out?
Where is PHI stored, processed, and transmitted?
What data retention and deletion policies apply to your PHI?
Has the vendor undergone a third-party HIPAA or SOC 2 audit?
What is the vendor's incident response and breach notification process?
Does the vendor offer audit logging for PHI access?
What subprocessors have access to PHI through this vendor?
Request Vendor Evaluation
Get a structured risk assessment for any vendor.
Request Benchmark Report
Compare vendors across your full stack.
Book Governance Assessment
Talk to a VNDRIQ governance specialist.